Search
Publication
Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose
This document offers a more detailed overview of the available scientific and epidemiological evidence and public health considerations in order to support decisions on the implementation of a second booster dose of COVID-19 vaccine.
Publication
Leaflet: Are you and your family protected from vaccine-preventable diseases?
Leaflet on vaccination for Ukrainian refugees.
Publication
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA
This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including updates on: vaccine uptake overall and by target group; vaccination strategies and policies in place; and vaccine acceptance and hesitancy.
Publication
Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update
This second update contains vaccine effectiveness results among individuals aged 30 years and older, for the pre-Delta and the Delta-dominant periods (3 January–31 May 2021 and 1 July–15 December 2021, respectively).
Publication
Considerations for the use of antibody tests for SARS-CoV-2 – first update
This report is the first update of a brief technical note that was developed at the request of the European Commission to inform the discussion on Digital Green Certificates to facilitate the safe and free movement of citizens within the EU during the COVID-19 pandemic.
Publication
COVID-19 vaccine effectiveness in adolescents aged 12–17 years and interim public health considerations for administration of a booster dose
The purpose of this document is to review the evidence of COVID-19 vaccine effectiveness and duration of immunity following vaccination in adolescents aged 12-17 years, and to outline interim public health considerations for the potential use of a booster dose in this group.
Publication
Assessment of the further spread and potential impact of the SARS-CoV-2 Omicron variant of concern in the EU/EEA, 19th update
The SARS-CoV-2 Omicron variant of concern (VOC) is rapidly replacing SARS-CoV-2 Delta in most European Union/European Economic Area (EU/EEA) countries, and is broadly following a west-to-east progression.
Publication
Assessment of the further emergence of the SARS-CoV-2 Omicron VOC in the context of the ongoing Delta VOC transmission in the EU/EEA, 18th update
The risk to public health posed by the spread of the Omicron VOC in the context of ongoing Delta VOC transmission in the EU/EEA is assessed in this update.
Publication
Generic protocol for COVID-19 vaccine effectiveness studies during outbreaks in semi-closed settings in the EU/EEA
ECDC encourages the use of this protocol as a basis for studies aiming at assessing vaccine effectiveness in semi-closed settings following the identification of a COVID-19 outbreak, as its use in the EU/EEA can facilitate results comparability from different outbreak investigations.
Publication
Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update
The number of countries reporting SARS-CoV-2 Omicron variant of concern (VOC) cases continues to increase globally, with a total of 352 confirmed cases reported by 27 countries as of 16.00 on 1 December 2021, including 70 confirmed cases reported by 13 European Union and European Economic Area (EU/EEA) countries.